Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients-Reference-Cited by-同舟云学术

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients

Published:2016-08-23 Issue:1 Volume:106 Page:58-68
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Stam-Slob Manon C.,Visseren Frank L. J.,Wouter Jukema J.,van der Graaf Yolanda,Poulter Neil R.,Gupta Ajay,Sattar Naveed,Macfarlane Peter W.,Kearney Patricia M.,de Craen Anton J. M.,Trompet Stella

Funder

ZonMw

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-016-1023-8.pdf

Reference41 articles.

1. Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O’Donnell M, Sullivan R, Yusuf S (2015) The burden of disease in older people and implications for health policy and practice. Lancet 385:549–562

2. Jaguszewski M, Ghadri JR, Diekmann J, Bataiosu RD, Hellermann JP, Sarcon A, Siddique A, Baumann L, Stahli BE, Luscher TF, Maier W, Templin C (2015) Acute coronary syndromes in octogenarians referred for invasive evaluation: treatment profile and outcomes. Clin Res Cardiol 104:51–58

3. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM (2003) Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam study. J Neurol Neurosurg Psychiatry 74:317–321

4. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623–1630

5. Kutner JS, Blatchford PJ, Taylor DH Jr, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP (2015) Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 175:691–700

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry;Nutrition, Metabolism and Cardiovascular Diseases;2023-11

2. Allgemeine Abschätzung des kardiovaskulären Risikos;DMW - Deutsche Medizinische Wochenschrift;2023-08

3. Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table;European Journal of Preventive Cardiology;2022-02-15

4. Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study;Blood Advances;2022-02-02

5. Cardiovascular risk prediction in healthy older people;GeroScience;2021-11-11